Because previous reports used endothelial cells [2], [8], [9] or oral squamoid cancer cells [3], the discrepancy in the effect of MAZ51 on VEGFR-3 phosphorylation in glioma cells could be due to differences in cell lines. This evidence concerns the gene FLT4 and glioma.